President Trump’s recent directive to 17 pharmaceutical manufacturers demanding that U.S. drug prices align with the lowest prices in other developed countries has thrust the issue of prescription drug affordability into the spotlight. The goal, making medications accessible for American patients, is one we all share. The path to achieving it matters, and the current […]
Author Archives: Robert Levin
Robert Levin is the president of the Alliance for Transparent and Affordable Prescriptions. He wrote this for InsideSources.com.
